Page last updated: 2024-08-17

methionine and Graft vs Host Disease

methionine has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Boukouaci, W; Cappelli, B; Chabannon, C; Corbacioglu, S; Gluckman, E; Kenzey, C; Maio, KT; Rafii, H; Rocha, V; Ruggeri, A; Scigliuolo, GM; Tamouza, R; Volt, F1

Other Studies

1 other study(ies) available for methionine and Graft vs Host Disease

ArticleYear
Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.
    British journal of haematology, 2021, Volume: 195, Issue:2

    Topics: Anemia, Sickle Cell; Case-Control Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA-A Antigens; HLA-B Antigens; Humans; Immunity; Immunotherapy; Interleukin-2; Killer Cells, Natural; Methionine; Polymorphism, Single Nucleotide; Protein Sorting Signals; Sex Characteristics; Threonine; Treatment Outcome

2021